Appropriateness of treatment recommendations for PPI in hospital discharge letters

European Journal of Clinical Pharmacology

Volumn 66, Issue 12, 2010, Pages 1265-1271

  Ahrens, Dirk ^a   Chenot, Jean François ^a   Behrens, Gesa ^a   Grimmsmann, Thomas ^b   Kochen, Michael M ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b Medical Review Board of the Statutory Health Insurance Funds Mecklenburg Vorpommern   (Germany)

Author keywords

Germany; Proton pump inhibitors

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; ESOMEPRAZOLE; LANSOPRAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; WARFARIN;

ARTICLE; BARRETT ESOPHAGUS; CLINICAL PRACTICE; CONTROLLED STUDY; DIGESTIVE SYSTEM ULCER; DRUG INDICATION; DUODENUM ULCER; DYSPEPSIA; ESOPHAGUS VARICES; EVIDENCE BASED MEDICINE; FEMALE; GASTRITIS; GASTROESOPHAGEAL REFLUX; GERMANY; HELICOBACTER INFECTION; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PEPTIC ULCER; POLYPHARMACY; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; STOMACH ULCER;

AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT DISCHARGE; PRACTICE GUIDELINES AS TOPIC; PROTON PUMP INHIBITORS;

EID: 78649318940     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-010-0871-9     Document Type: Article

References (38)

1. Mössner J (2009) Magen Darm Mittel und Laxantien. In: Schwabe U, Paffrath D (eds) Drug prescription report 2009 [Arzneiverordnungsreport 2009]. Springer, Heidelberg, pp 653-681
2. P Moayyedi NJ Talley 2006 Gastro-oesophageal reflux disease Lancet 367 2086 2100 10.1016/S0140-6736(06)68932-0 16798392
3. Leontiadis GI, Sharma VK, Howden CW (2006) Proton pump inhibitor treatment for acute peptic ulcer bleeding. Cochrane Database Syst Rev CD002094
4. P Malfertheiner F Megraud C O'Morain F Bazzoli E El Omar D Graham, et al. 2007 Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report Gut 56 772 781 1:STN:280:DC%2BD2szkslaksw%3D%3D 10.1136/gut.2006.101634 17170018 (Pubitemid 46854190)
5. RW Dubois GY Melmed JM Henning L Laine 2004 Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2- specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapy Aliment Pharmacol Ther 19 197 208 1:STN:280: DC%2BD2c%2FmvV2qtA%3D%3D 10.1111/j.0269-2813.2004.01834.x 14723611 (Pubitemid 38174889)
6. FK Chan DY Graham 2004 Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications-review and recommendations based on risk assessment Aliment Pharmacol Ther 19 1051 1061 1:CAS:528:DC%2BD2cXlsVaju7k%3D 10.1111/j.1365-2036.2004.01935.x 15142194 (Pubitemid 38703517)
7. FL Lanza FK Chan EM Quigley 2009 Guidelines for prevention of NSAID-related ulcer complications Am J Gastroenterol 104 728 738 10.1038/ajg.2009.115 19240698
8. JP Quenot N Thiery S Barbar 2009 When should stress ulcer prophylaxis be used in the ICU? Curr Opin Crit Care 15 139 143 10.1097/MCC.0b013e32832978e0 19578324
9. D Armstrong JK Marshall N Chiba R Enns CA Fallone R Fass, et al. 2005 Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - update 2004 Can J Gastroenterol 19 15 35 15685294
10. NJ Talley N Vakil 2005 Guidelines for the management of dyspepsia Am J Gastroenterol 100 2324 2337 10.1111/j.1572-0241.2005.00225.x 16181387
11. F Lodato F Azzaroli M Di Girolamo V Feletti P Cecinato A Lisotti, et al. 2008 Proton pump inhibitors in cirrhosis: tradition or evidence based practice? World J Gastroenterol 14 2980 2985 10.3748/wjg.14.2980 18494046
12. FH Ng KF Lam SY Wong CM Chang YK Lau WC Yuen, et al. 2008 (2009) Upper gastrointestinal bleeding in patients with aspirin and clopidogrel co-therapy Digestion 77 173 177 1:CAS:528:DC%2BD1cXhtVejtrbJ 10.1159/000141264 18577887
13. O'Donoghue ML, Braunwald E, Antman EM, Murphy SA, Bates ER, Rozenman Y, et al. Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials. Lancet 374:989-997
14. PM Ho TM Maddox L Wang SD Fihn RL Jesse ED Peterson, et al. 2009 Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome JAMA 301 937 944 1:CAS:528:DC%2BD1MXivFejt7g%3D 10.1001/jama.2009.261 19258584
15. AZ Mat Saad N Collins MM Lobo HJ O'Connor 2005 Proton pump inhibitors: a survey of prescribing in an Irish general hospital Int J Clin Pract 59 31 34 1:STN:280:DC%2BD2M%2FnvFWgsg%3D%3D 10.1111/j.1742-1241.2004.00298.x 15707461 (Pubitemid 40260110)
16. A Niklasson A Bajor L Bergendal M Simren H Strid E Bjornsson 2003 Overuse of acid suppressive therapy in hospitalised patients with pulmonary diseases Respir Med 97 1143 1150 1:STN:280:DC%2BD3svot1Gntg%3D%3D 10.1016/S0954-6111(03) 00187-2 14561022 (Pubitemid 37185118)
17. R Scagliarini E Magnani A Pratico R Bocchini P Sambo P Pazzi 2005 Inadequate use of acid-suppressive therapy in hospitalized patients and its implications for general practice Dig Dis Sci 50 2307 2311 1:CAS:528: DC%2BD28XksVOrtA%3D%3D 10.1007/s10620-005-3052-4 16416179 (Pubitemid 43108975)
18. H Strid M Simren ES Bjornsson 2003 Overuse of acid suppressant drugs in patients with chronic renal failure Nephrol Dial Transplant 18 570 575 1:CAS:528:DC%2BD3sXit1yktLk%3D 10.1093/ndt/18.3.570 12584281 (Pubitemid 36305664)
19. DA Zink M Pohlman M Barnes ME Cannon 2005 Long-term use of acid suppression started inappropriately during hospitalization Aliment Pharmacol Ther 21 1203 1209 1:STN:280:DC%2BD2M3ktlyhsg%3D%3D 10.1111/j.1365-2036.2005. 02454.x 15882240 (Pubitemid 40733485)
20. AP Hungin GP Rubin H O'Flanagan 1999 Long-term prescribing of proton pump inhibitors in general practice Br J Gen Pract 49 451 453 1:STN:280: DC%2BD3c%2FivVCrtg%3D%3D 10562744
21. F Parente C Cucino S Gallus S Bargiggia S Greco L Pastore, et al. 2003 Hospital use of acid-suppressive medications and its fall-out on prescribing in general practice: a 1-month survey Aliment Pharmacol Ther 17 1503 1506 1:STN:280:DC%2BD3s3psFOmsg%3D%3D 10.1046/j.1365-2036.2003.01600.x 12823152 (Pubitemid 36833294)
22. P Vestergaard L Rejnmark L Mosekilde 2006 Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture Calcif Tissue Int 79 76 83 1:CAS:528:DC%2BD28XosleqtL0%3D 10.1007/s00223-006-0021-7 16927047 (Pubitemid 44306164)
23. YX Yang JD Lewis S Epstein DC Metz 2006 Long-term proton pump inhibitor therapy and risk of hip fracture JAMA 296 2947 2953 1:CAS:528:DC%2BD2sXnvVGn 10.1001/jama.296.24.2947 17190895 (Pubitemid 46021498)
24. S Dial JA Delaney AN Barkun S Suissa 2005 Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease JAMA 294 2989 2995 1:CAS:528:DC%2BD2MXhtleltL7P 10.1001/jama.294.23.2989 16414946 (Pubitemid 41817660)
25. RJ Laheij MC Sturkenboom RJ Hassing J Dieleman BH Stricker JB Jansen 2004 Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs JAMA 292 1955 1960 1:CAS:528:DC%2BD2cXptVeksr0%3D 10.1001/jama.292.16.1955 15507580 (Pubitemid 39411203)
26. M Wurtz EL Grove SD Kristensen AM Hvas 2010 The antiplatelet effect of aspirin is reduced by proton pump inhibitors in patients with coronary artery disease Heart 96 368 371 1:CAS:528:DC%2BC3cXks1SjsLk%3D 10.1136/hrt.2009.181107 19910291
27. JM Piper WA Ray JR Daugherty MR Griffin 1991 Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs Ann Intern Med 114 735 740 1:STN:280:DyaK3M7ovFGlsA%3D%3D 2012355
28. GW Petty RD Brown Jr JP Whisnant JD Sicks WM O'Fallon DO Wiebers 1999 Frequency of major complications of aspirin, warfarin, and intravenous heparin for secondary stroke prevention. A population-based study Ann Intern Med 130 14 22 1:CAS:528:DyaK1MXltF2gtQ%3D%3D 9890845
29. DJ Cook HD Fuller GH Guyatt JC Marshall D Leasa R Hall, et al. 1994 Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group N Engl J Med 330 377 381 1:STN:280: DyaK2c7htFOnsg%3D%3D 10.1056/NEJM199402103300601 8284001 (Pubitemid 24045653)
30. ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis 1999 ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 14, 1998 Am J Health Syst Pharm 56 347 379
31. S Redeen F Petersson KA Jonsson K Borch 2003 Relationship of gastroscopic features to histological findings in gastritis and Helicobacter pylori infection in a general population sample Endoscopy 35 946 950 1:STN:280:DC%2BD3srislWjtg%3D%3D 10.1055/s-2003-43479 14606018 (Pubitemid 37368820)
32. T Sauerbruch MA Schreiber P Schussler W Permanetter 1984 Endoscopy in the diagnosis of gastritis. Diagnostic value of endoscopic criteria in relation to histological diagnosis Endoscopy 16 101 104 1:STN:280:DyaL2c3jsFymsQ%3D%3D 10.1055/s-2007-1018546 6734532
33. G Sachs JM Shin CW Howden 2006 Review article: the clinical pharmacology of proton pump inhibitors Aliment Pharmacol Ther 23 Suppl 2 2 8 1:CAS:528:DC%2BD28XntlWqt78%3D 10.1111/j.1365-2036.2006.02943.x 16700898 (Pubitemid 44383831)
34. PM Hellstrom S Vitols 2004 The choice of proton pump inhibitor: does it matter? Basic Clin Pharmacol Toxicol 94 106 111 10.1111/j.1742-7843.2004. pto940302.x 15049339
35. T Grimmsmann U Schwabe W Himmel 2007 The influence of hospitalisation on drug prescription in primary care-a large-scale follow-up study Eur J Clin Pharmacol 63 783 790 10.1007/s00228-007-0325-1 17549465 (Pubitemid 47052053)
36. MM Kochen W Niebling 2006 Proton pump inhibitors-information on rational pharmacotherapy in primary care [Protonenpumpenhemmer- Informationen zur rationalen Arzneitherapie in der hausärztlichen Praxis] Arzneitelegramm 37 104 06
37. JW Freston 2001 Review article: role of proton pump inhibitors in non-H. pylori-related ulcers Aliment Pharmacol Ther 15 Suppl 2 2 5 1:CAS:528: DC%2BD3MXnt1Gjs74%3D 10.1046/j.1365-2036.2001.00114.x 11556873
38. CM Wilcox BI Hirschowitz 2009 Treatment strategies for Zollinger-Ellison syndrome Expert Opin Pharmacother 10 1145 1157 1:CAS:528:DC%2BD1MXlt1Sktbs%3D 10.1517/14656560902887035 19351273